Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CBER/CDER Consolidation: Weiss Named Acting Director Of New ODE VI

Executive Summary

CBER Office of Therapeutics Research & Review Acting Director Sharon Risso will continue to serve as the point person for biologics staff transition questions after the consolidation with FDA's drugs center

You may also be interested in...



FDA Reorganization Plan Would Eliminate One ODE, Split Neuropharm Division

FDA is planning to split the Division of Neuropharmacological Drug Products into two divisions - neurology and psychiatry - as part of the upcoming reorganization of the Office of New Drugs

FDA Reorganization Plan Would Eliminate One ODE, Split Neuropharm Division

FDA is planning to split the Division of Neuropharmacological Drug Products into two divisions - neurology and psychiatry - as part of the upcoming reorganization of the Office of New Drugs

FDA names ODE VI deputy director

David Ross, MD/PhD, has been appointed deputy director of Center for Drug Evaluation & Research's Office of Drug Evaluation VI. Effective April 18, he will report to office director Karen Weiss, MD. Weiss was named to the post in June (1"The Pink Sheet" June 23, 2003, p. 24)...

Related Content

UsernamePublicRestriction

Register

PS041993

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel